Guangdong Bawei Biotechnology Co., Ltd. is engaged in the professional planning, research and development, production and sales of cosmetics, currently has no own brand, mainly to other brand customers, to provide production, research and development, planning as one of the processing services, the company is currently applying for listing on the Beijing Stock Exchange.
According to the prospectus, the actual controller and chairman of Bawei shares is Leng Qunying, who previously served as the general manager of Guangzhou Yagaoli Cosmetics from September 1998 to June 2003; At the same time, Gao Yi, the director of Bawei Co., Ltd. and the deputy general manager of the marketing center, also served as the purchasing manager of Guangzhou Yagaoli Cosmetics from December 1998 to May 2006.
However, according to the "Other Enterprises Controlled by Controlling Shareholders and Actual Controllers" disclosed in the prospectus, "Guangzhou Yagaoli Cosmetics was registered and established in September 1999, which is a whole year later than Leng Qunying as general manager and 9 months later than Gao Yi as purchasing manager." And according to "Tianyancha", "Leng Qunying, the legal representative of Guangzhou Yagaoli Cosmetics*** before the cancellation in September 2023, is the only senior executive listed, which also contradicts the information that he held the position of general manager of the company until June 2003."
In addition, regarding the reasons why the business license of Guangzhou Yagaoli Cosmetics was revoked in December 2007, and who served as the general manager of the company from June 2003 to December 2007, Bawei shares did not accept interviews with reporters.
Looking at the operating data of Bawei shares, according to the disclosure of related parties and related party transactions, the related parties identified in the prospectus include the "Guangdong Provincial Functional Cosmetics Research Institute", which mentioned in the "Reply to the Audit Inquiry Letter" that the funds are Leng Yanchun's own funds, and there is no ** situation in the issuer or the actual controller of the issuer. However, according to "Tianyancha", the contact email address announced by the "Guangdong Provincial Institute of Functional Cosmetics" in the 2021 annual report is the public information disclosure email address of Bawei shares, and the contact ** also belongs to Bawei shares.
In addition, Renhe Group is the largest customer of Bawei shares in 2022, involving a sales amount of more than 8,600 yuan. In addition, according to the "Reply to the Audit Inquiry Letter", Renhe Group refers to Beijing Heshenghuikang Technology***Shenzhen Miura Natural Cosmetics***Jiangxi Hehe Industry***Jiangxi Dingdang Health Pharmacy Chain***Jiangxi Juhe E-commerce***Jiangxi Renhe Health Technology***, but according to public information, "the shareholders of Beijing Heshenghuikang Technology*** are Liu Xing and Liang Guanyun, and there is no direct relationship with Renhe Group from the perspective of the company's shareholding structure."
According to data disclosure, the fixed assets of machinery and equipment of Bawei shares will increase significantly in the first half of 2023, from 7905 at the end of 2022390,000 yuan increased to 9,254 by the end of the first half of 202370,000 yuan, an increase of about 15%. But at the same time, according to the company's disclosure of "the company's production capacity, output, and sales volume", the production capacity in the first half of 2023 will be 477950,000 kilograms, an annualized rate of less than 10 million kilograms, significantly lower than the annual production capacity of 12.29 million kilograms in 2022.